Related Experiment Video
Updated: Dec 14, 2025

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
Published on: April 9, 2021
Experience of a novel community testing programme for COVID-19 in London: Lessons learnt
Gabriel Wallis1, Francesca Siracusa2, Michael Blank1
1London North West University Healthcare NHS Trust, Harrow, UK.
None:
We describe the London community testing programme developed for COVID-19, audit its effectiveness and report patient acceptability and patient adherence to isolation guidance, based upon a survey conducted with participants.Any patients meeting the Public Health England (PHE) case definition for COVID-19 who did not require hospital admission were eligible for community testing. 2,053 patients with suspected COVID-19 were tested in the community between January and March 2020. Of those tested, 75 (3.6%) were positive. 88% of patients that completed a patient survey felt safe and 82% agreed that community testing was preferable to hospital admission. 97% were able to remain within their own home during the isolation period but just 41% were able to reliably isolate from other members of their household.The London community testing programme allowed widespread testing for COVID-19 while minimising patient transport, hospital admissions and staff exposures. Community testing was acceptable to patients and preferable to admission to hospital. Patients were able to reliably isolate in their home but not from household contacts. The authors believe in the importance, feasibility and acceptability of community testing for COVID-19 as a part of a package of interventions to mitigate a second wave of infection.
Related Concept Videos
Steps in Outbreak Investigation
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Principles of Disease Surveillance
Controls in Experiments
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...

